MOBILAT

This brand name is authorized in Finland, Germany, Netherlands, Poland, Romania.

Active ingredients

The drug MOBILAT contains a combination of these active pharmaceutical ingredients (APIs):

1
Mucopolysaccharide polysulfate
 

Heparinoid is recognised as having: a weak inhibitory effect on PGE2 synthesis and an indirect effect on LTB4 production (based on in vitro studies), anti-coagulant activity (as a heparinoid), thrombolytic activity (through potentiation of urokinase activity), anti-exudatory activity (through inhibition of hyaluronidase).

2
UNII O414PZ4LPZ - SALICYLIC ACID
 

Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.

 
Read more about Salicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C05BA51 Heparinoid, combinations C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BA Heparins or heparinoids for topical use
Discover more medicines within C05BA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00412493, 03817003
FI Lääkealan turvallisuus- ja kehittämiskeskus 012249, 095829, 095840, 489393, 585463, 585471
NL Z-Index G-Standaard 13602640, 13602675
NL Z-Index G-Standaard, PRK 83666
PL Rejestru Produktów Leczniczych 100044342, 100219439, 100464005
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W43281001, W43282001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.